Israel's MediWound announces launch of biologic drug NexoBrid in Japan

Israel-based biopharma firm MediWound has announced that its strategic partner, Kaken Pharmaceutical has launched NexoBr...

August 2, 2023 | Wednesday | News
US-based Rani Therapeutics expands biologics partnership with Korean firm Celltrion

Rani Therapeutics Holdings, a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs...

June 8, 2023 | Thursday | News
Aptamer Group consortium awarded Eurostars grant to develop a novel prenatal disease diagnostic device

Current prenatal diagnostic methods are highly invasive, carrying risk of miscarriage, infection, and injury to the foet...

May 23, 2023 | Tuesday | News
LogiPharma to launch life sciences supply chain conference summit in Singapore (June 2023)

LogiPharma, the global life sciences supply chain conference brand will be holding its inaugural Asian summit from June ...

March 28, 2023 | Tuesday | Company results
Register Now :10x Genomics to host APAC Spatial Biology Symposium on November 22

The future of spatial is here. Join us: https://10xgen.com/3fn3FZw      Advances in spatial technologi...

November 1, 2022 | Tuesday | News
Biocon out-licenses two biosimilar assets for commercialization in Japan

Indian firm Biocon Biologics has entered into a strategic out-licensing agreement with Japanese pharmaceuticals com...

October 17, 2022 | Monday | News
Pall Corporation Launches Three New Allegro™ Connect Systems

Pall Corporation extends its bioprocessing solution portfolio with the launch of three new Allegro Connect Systems. In c...

September 27, 2022 | Tuesday | News
Thermo Fisher invests $160 M to expand bioproduction capacity in Greater Boston

Thermo Fisher Scientific Inc., the world leader in serving science, has opened a new biomanufacturing facility in Chelms...

September 20, 2022 | Tuesday | News
Polyplus Builds on Research and Commercial mRNA Support Portfolio with in vivo-jetRNA®+ Transfection Reagent

The new in vivo-jetRNA®+ transfection reagent an efficient, stable, and safe delivery system leading to 100% mR...

September 8, 2022 | Thursday | News
Japan's EditForce & Mitsubishi ink gene therapy deal for ¥20 B

Japan-based EditForce has entered into a license agreement with Mitsubishi Tanabe Pharma Corporation (MTPC) to research,...

July 5, 2022 | Tuesday | News
VerImmune and Fosun Pharma focus on virus-inspired particle based novel immunotherapies in China

US-based  startup VerImmune and Fosun Pharma in China have entered into an exclusive license and option agreement. ...

May 23, 2022 | Monday | News
South Korean firms lay focus on immune cell therapy

Daewoong Pharmaceutical has signed a joint research and development agreement with UCI Therapeutics (CEO Sooyoung Jung),...

April 29, 2022 | Friday | News
Korean startup ImmuneOncia enhances biologics portfolio for cancer patients

ImmuneOncia Therapeutics, Inc., a clinical-stage, immuno-oncology startup in South Korea, has announced that a Memorandu...

December 28, 2021 | Tuesday | News
'Biocon Biologics to work with RSSDI to train ~400 HCPs in India'

What additional scientific data did you have to submit to the US FDA for obtaining interchangeable biosimilar approval f...

December 1, 2021 | Wednesday | Opinion
China-based BeiGene to open manufacturing site in US for advanced new medicines

BeiGene, headquartered in China, has purchased a 42-acre site at the Princeton West Innovation Campus in Hopewell, N.J.,...

November 24, 2021 | Wednesday | News
Masco Group Acquire Keyplants AB, a Leading Global Provider of Modular Life Science Facilities

KeyPlants is a leading international industry partner for standardized as well as customized process-integrated modular ...

November 9, 2021 | Tuesday | News
Singapore scientists discover a novel strategy to tame aggressive breast cancer

A team of clinicians and scientists from the National Cancer Centre Singapore (NCCS), Singapore General Hospital (SGH) a...

October 7, 2021 | Thursday | News
ValenzaBio partners ProBioGen to maximize cell line productivity in Europe

ProBioGen and ValenzaBio jointly initiate a cell line development project involving the application of ProBioG...

August 9, 2021 | Monday | News